
Sign up to save your podcasts
Or


A novel non-opiate medication option for control of acute pain.
References:
1) OpenEvidence Information on Journavx
2) FDA Information on Journavx
3) GLP-1 Price Reduction Article (CNBC)
4) Vanderbilt LifeFlight Crash (WBRC)
By Jody Marks, MSN, AGACNP-BC, FNP-BC5
99 ratings
A novel non-opiate medication option for control of acute pain.
References:
1) OpenEvidence Information on Journavx
2) FDA Information on Journavx
3) GLP-1 Price Reduction Article (CNBC)
4) Vanderbilt LifeFlight Crash (WBRC)

1,869 Listeners

3,369 Listeners

1,149 Listeners

316 Listeners

485 Listeners